Loading organizations...
SCP Ventures is a venture capital firm specializing in early-stage healthcare, focusing on medical technologies and IT services. It provides capital and strategic advice across Seed, Series A, and Series B rounds, reserving funds for follow-on. The firm leverages partner expertise and networks to support growth, particularly within Asian markets. Its operational model emphasizes a value-added approach, extending beyond mere financial investment.
The firm originated in 2015 from partners of Sustainergy Capital, founded in 2012. This venture was built on the insight that early-stage companies benefit from value-added advice, not just capital. Founding Partner Bryant Dun contributes nearly two decades of private equity and venture capital experience, with prior roles at Park Avenue Equity Partners and Deutsche Bank, showcasing significant financial expertise.
SCP Ventures targets early-stage healthcare companies developing disruptive medical technologies or IT services. The firm seeks to improve healthcare access and drive significant investor value. It supports portfolio companies through growth stages, fostering innovation beneficial to both the industry and broader society, thereby contributing to the future of healthcare.
SCP Ventures has 1 tracked investment across 1 company. The latest tracked deal is $1.8M Seed in ConKay Medical Systems in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2024 | ConKay Medical Systems | $1.8M Seed | — | Carey Smith, WS Investment Company |